These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 19623905)

  • 1. Current issues in coronary stent technology.
    Shedden L; Oldroyd K; Connolly P
    Proc Inst Mech Eng H; 2009 Jul; 223(5):515-24. PubMed ID: 19623905
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Degradable, drug-eluting stents: a new frontier for the treatment of coronary artery disease.
    Kohn J; Zeltinger J
    Expert Rev Med Devices; 2005 Nov; 2(6):667-71. PubMed ID: 16293093
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Coronary restenotic reduction of drug-eluting stenting may be due to its anti-inflammatory effects.
    Li JJ; Li J; Nan JL; Li Z; Zhen X; Mu CW; Dai J; Zhang CY
    Med Hypotheses; 2007; 69(5):1004-9. PubMed ID: 17499449
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Coronary intervention. 2012 update].
    Rittger H; Arnold M; Schmid M; Zimmermann S; Daniel WG
    Herz; 2012 Mar; 37(2):123-7. PubMed ID: 22382138
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The future of CART in the era of drug eluting stents: "It's not over until it's over". Counterpoint.
    Tripuraneni P
    Brachytherapy; 2003; 2(2):74-6. PubMed ID: 15062143
    [No Abstract]   [Full Text] [Related]  

  • 6. A prospective randomised study using optical coherence tomography to assess endothelial coverage and neointimal proliferation at 6-months after implantation of a coronary everolimus-eluting stent compared with a bare metal stent postdilated with a paclitaxel-eluting balloon (OCTOPUS Trial): rationale, design and methods.
    Poerner TC; Otto S; Gassdorf J; Janiak F; Danzer C; Ferrari M; Figulla HR
    EuroIntervention; 2011 May; 7 Suppl K():K93-9. PubMed ID: 22027737
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Review of the TAXUS Liberté SR paclitaxel-eluting coronary stent.
    Ahmed WH
    Expert Rev Med Devices; 2007 Mar; 4(2):117-20. PubMed ID: 17359218
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Coating bioabsorption and chronic bare metal scaffolding versus fully bioabsorbable stent.
    Waksman R; Pakala R
    EuroIntervention; 2009 Dec; 5 Suppl F():F36-42. PubMed ID: 22100674
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A randomized optical coherence tomography study of coronary stent strut coverage and luminal protrusion with rapamycin-eluting stents.
    Moore P; Barlis P; Spiro J; Ghimire G; Roughton M; Di Mario C; Wallis W; Ilsley C; Mitchell A; Mason M; Kharbanda R; Vincent P; Sherwin S; Dalby M
    JACC Cardiovasc Interv; 2009 May; 2(5):437-44. PubMed ID: 19463468
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drug-eluting stents.
    García-García HM; Vaina S; Tsuchida K; Serruys PW
    Arch Cardiol Mex; 2006; 76(3):297-319. PubMed ID: 17091802
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The future of coronary artery radiation therapy--"the CART before the (unbridled) horse!". Point.
    Devlin PM
    Brachytherapy; 2003; 2(2):73-4. PubMed ID: 15062142
    [No Abstract]   [Full Text] [Related]  

  • 12. Evaluation of patients with previous coronary stent implantation with 64-section CT.
    Schuijf JD; Pundziute G; Jukema JW; Lamb HJ; Tuinenburg JC; van der Hoeven BL; de Roos A; Reiber JH; van der Wall EE; Schalij MJ; Bax JJ
    Radiology; 2007 Nov; 245(2):416-23. PubMed ID: 17890353
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intravascular ultrasound-guided percutaneous coronary interventions in contemporary practice.
    Bonello L; De Labriolle A; Lemesle G; Roy P; Steinberg DH; Pichard AD; Waksman R
    Arch Cardiovasc Dis; 2009 Feb; 102(2):143-51. PubMed ID: 19303582
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Position paper on the use of drug eluting stents in coronary heart disease].
    Mudra H; Bode C; Grube E; de Haan F; Levenson B; Schuler G; Silber S; ;
    Z Kardiol; 2004 May; 93(5):416-22. PubMed ID: 15160279
    [No Abstract]   [Full Text] [Related]  

  • 15. Drug-eluting versus bare-metal coronary stents: where are we now?
    Amoroso NS; Bangalore S
    J Comp Eff Res; 2012 Nov; 1(6):501-8. PubMed ID: 24236469
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Angioscopic findings after drug-eluting stent implantation.
    Takano M; Mizuno K
    Herz; 2007 Jun; 32(4):281-6. PubMed ID: 17607534
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In-stent restenosis is inhibited in a bare metal stent implanted distal to a sirolimus-eluting stent to treat a long de novo coronary lesion with small distal vessel diameter.
    Obata JE; Nakamura T; Kitta Y; Saito Y; Sano K; Fujioka D; Kawabata K; Kugiyama K
    Catheter Cardiovasc Interv; 2013 Nov; 82(6):E777-87. PubMed ID: 23378231
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Towards a self-reporting coronary artery stent--measuring neointimal growth associated with in-stent restenosis using electrical impedance techniques.
    Shedden L; Kennedy S; Wadsworth R; Connolly P
    Biosens Bioelectron; 2010 Oct; 26(2):661-6. PubMed ID: 20667708
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Randomized double-blind comparison of sirolimus-eluting stent versus bare-metal stent implantation in diseased saphenous vein grafts: six-month angiographic, intravascular ultrasound, and clinical follow-up of the RRISC Trial.
    Vermeersch P; Agostoni P; Verheye S; Van den Heuvel P; Convens C; Bruining N; Van den Branden F; Van Langenhove G
    J Am Coll Cardiol; 2006 Dec; 48(12):2423-31. PubMed ID: 17174178
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recent progress in percutaneous coronary intervention: evolution of the drug-eluting stents, focus on the XIENCE V drug-eluting stent.
    Doostzadeh J; Clark LN; Bezenek S; Pierson W; Sood PR; Sudhir K
    Coron Artery Dis; 2010 Jan; 21(1):46-56. PubMed ID: 19952925
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.